What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 40.2% in the afternoon session after the company ...

Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the ...

Patients taking the GLP-1 weight loss drug Zepbound face mandatory switch to Wegovy after CVS Caremark removed the Eli Lilly medication from its preferred coverage list, citing rising costs.

The 50-year-old is now on Novo Nordisk ’s Wegovy, but worries because it is less effective. Studies have shown Wegovy helps people lose less weight, on average, than Zepbound.

Novo Nordisk shares plunged over 20% on Tuesday after the company named a new CEO and lowered its profit expectations, citing weaker sales of its popular weight-loss drug Wegovy due to competition ...

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in ...

FILE PHOTO: Wegovy maker Novo Nordisk said it will cut the price of the weight-loss medication to $199 for one month for new customers. The move comes as the FDA phases out compounded versions of ...

A generic version of Wegovy is not currently available in the United States due to existing patents held by the manufacturer, Novo Nordisk, that may be active until 2041. When the U.S. patent for ...

Wegovy is having a moment — again. Novo Nordisk’s blockbuster weight-loss drug just saw prescriptions skyrocket by 33 percent after a U.S. ban on compounded copycat versions. Sounds like a win ...

While it’s not clear why semaglutide is linked to greater hair loss than older weight-loss drugs, Sodhi says scientists have some theories. The first relates to the physiological stress that the ...